Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
about
The notch ligand JAGGED1 as a target for anti-tumor therapySkeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myelomaMultiple myeloma cancer stem cellsNotch Signaling in Neuroendocrine TumorsNotch signaling: its roles and therapeutic potential in hematological malignanciesCancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?Notch signaling deregulation in multiple myeloma: A rational molecular targetThe tumor microenvironment shapes hallmarks of mature B-cell malignancies.Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma.NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomasGrowth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays.Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesisNotch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model.Notch inhibitors for cancer treatment.miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets.Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.Notch signaling in serous ovarian cancer.Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect.Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.Eosinophils and megakaryocytes support the early growth of murine MOPC315 myeloma cells in their bone marrow nichesTherapeutic approaches to modulating Notch signaling: current challenges and future prospects.Bone marrow microenvironment and the identification of new targets for myeloma therapy.Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.Notch signaling in T-cell acute lymphoblastic leukemia.Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomasBidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple MyelomaStructure and function of the solid tumor niche.Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment.Multiple myeloma cancer stem cellsGamma secretase inhibitors of Notch signalingNotch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transitionNotch1 mediates growth suppression of papillary and follicular thyroid cancer cells by histone deacetylase inhibitors.Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progressionTargeting the Notch signaling pathway in autoimmune diseases.
P2860
Q21129294-23F9171C-AF01-4B3F-B65B-BA560156E05AQ24675624-3C4FCE28-129E-4832-B57D-07433B53CFCFQ26752365-08C3322B-EC32-4330-B4CC-7201FB7CD8CFQ26752380-7D12C4C9-B787-4B56-B34C-77E19BE6EBF1Q26765033-B37B8853-49E2-428F-9F69-150DA9E6E4F4Q26785497-5EB50CD4-0F2F-4A58-A151-BB854E0D8D41Q26797283-046797BF-BB6E-43B6-85BA-1527E35A5550Q27687567-CBFEE21D-AEB9-49CB-B5CC-93ED16FA0BEEQ33229068-F63CB8CC-0434-4066-937C-C2C43D82A462Q33567153-0D976687-4B6D-4A8B-81F4-4C17A9358A21Q33577408-7F288A2E-979C-4257-A137-4B173C0C23D9Q33601436-7788DD7C-1814-4B21-B664-3932C573A305Q33840195-BB53B795-11E9-46EE-A042-2B222FEF480CQ34330869-7722C173-C455-441B-93FE-59F45967EB79Q34369490-111F17BF-3CCE-40E7-AF51-A622C8119F71Q34376282-9A42527C-B8C7-4372-8E7B-7C9804276E51Q34491211-5244E17D-D054-4C75-A2C4-A780D268E29EQ34683589-DE26F68A-32D2-4290-8628-D4C955196580Q35196364-BCDFED11-23A0-493A-B2E8-1EDAA3DBF8DDQ35256272-3085BE0D-DE94-4B9A-8BCF-A455132E40EAQ35291672-A5850735-83F7-4176-BD53-295083DA0FEFQ36024533-E5487279-6369-481E-9144-AE4A66DBEC73Q36162703-BBFFA56D-1365-4DDE-9621-A43B60A26308Q36367811-7E469796-2596-4D3C-9EAD-2766EFC441FFQ36429535-E5F8D0E5-B670-407A-8C36-A9357BA55F8EQ36529184-8161E31E-6CD8-4D81-B8AD-292D2AC33E17Q36621195-F86038A9-76F8-44E2-A235-7E7D35657B59Q36642956-E7CB296C-2DFE-4F77-91D5-67BBF056A258Q36676448-A8D2A9A3-3527-4E4A-AF21-F86A5831AF78Q36962815-480432BD-9CA1-42C8-A38C-7014CE7A4F87Q37013225-855E7FE0-A488-454D-9858-029943A55F37Q37029171-ABBBAF9A-6FCB-44E6-8349-8E9847B097A0Q37053722-13B69824-DA12-4FB4-8C2D-4128817DBAAAQ37169972-2C5EE8BA-12A6-446B-96E9-CA9D9898F8BBQ37171078-3EF594D3-A157-4050-B8D4-BDD4090BE8E6Q37234638-003BD2AB-DDEA-4F68-A36C-DB0A31C0733CQ37308441-94D71617-51DA-4160-990F-F308CEC197B1Q37636576-DD77E21B-85FA-4D76-A0C9-376AEBF33557Q37700357-3541E73A-108C-464E-86C7-033B49FD7327Q37718251-FDA0D5CF-B64E-420A-825C-86562D090C6C
P2860
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
@en
type
label
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
@en
prefLabel
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
@en
P2093
P1433
P1476
Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.
@en
P2093
Bernd Dörken
Gwendolin Muehlinghaus
Harald Stein
Ioannis Anagnostopoulos
Kristina Schulze Pröbsting
Manik Chatterjee
Ralf C Bargou
Rudolf Manz
Stephan Mathas
P304
P356
10.1182/BLOOD-2003-07-2254
P407
P577
2004-01-15T00:00:00Z